Both tumor-promoting and tumor-suppressing activities have been reported for EphA4 (9, 10, 11, 12, 13, 14, 15, 16, 21), suggesting that the consequences of EphA4 activation in cancer cells may vary, for example, depending on the cellular context. The gene discussed is EPHA4; the disease is cancer.